Background Irritable bowel syndrome (IBS) is a chronic functional bowel disorder.
Disturbances in the gastrointestinal microbiome may be involved in its aetiology. Aim To …

OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder that is
thought to be due to a disorder of brain–gut function. Drugs acting centrally, such as …

OBJECTIVES: Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are
functional bowel disorders. Evidence suggests that disturbance in the gastrointestinal …

METHODS We have conducted a series of systematic reviews on the efficacy of therapy in
IBS and CIC. There have been several systematic reviews of therapy for IBS and CIC …

OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal
disorder. Evidence relating to the treatment of this condition with antidepressants and …

Background Evidence suggests that gut flora may play an important role in the
pathophysiology of the irritable bowel syndrome (IBS). We evaluated rifaximin, a minimally …

Background Placebo treatment can significantly influence subjective symptoms. However, it
is widely believed that response to placebo requires concealment or deception. We tested …

OBJECTIVES: Fiber has been used for many years to treat irritable bowel syndrome (IBS).
This approach had fallen out of favor until a recent resurgence, which was based on new …

Согласно Римским критериям III, синдромраздраженного кишечника (СРК)
определяется как функциональное расстройство, при котором боль или дискомфорт в …

S3 Evidence-Based Systematic Review on Medical Therapies for IBD also has a high
incidence in New Zealand, suggesting that the disease may get more common the further …